| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a009131ba0f58a670a701101253a582 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2123-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1045 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-534
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
1993-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c51f477bdc4e62fa59a4fb2ff74d28f |
| publicationDate |
1994-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H06312944-A |
| titleOfInvention |
Tumor or infectious lesion tissue localization composition |
| abstract |
(57) [Summary] [Purpose] Circulating labeled antibody that enhances the localization of labeled related marker-specific antibody or antibody fragment used for localization of tumor or infectious tissue lesion and is not targeted And a composition for diagnostic purposes to reduce antibody fragments. A first marker-specific antibody or antibody fragment labeled with a label such as a radioisotope capable of detecting external non-invasion And the second injectable composition containing a second unlabeled antibody or antibody fragment specific for the first marker-specific antibody or antibody fragment as a main component. The second injection is administered after the antibody or antibody fragment labeled by the tumor or diseased tissue is ingested by the administration of the first injection, and then scanned. |
| priorityDate |
1983-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |